Role of lopinavir/ritonavir in the treatment of SARS: Initial virological and clinical findings

Thorax

Volumn 59, Issue 3, 2004, Pages 252-256

  Chu, C M ^b   Cheng, V C C ^a   Hung, I F N ^a   Wong, M M L ^c   Chan, K H ^a   Chan, K S ^b   Kao, R Y T ^a   Poon, L L M ^a   Wong, C L P ^a   Guan, Y ^a   Peiris, J S M ^a   Yuen, K Y ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNITED CHRISTIAN HOSPITAL   (Hong Kong)

^c Caritas Medical Centre Hong Kong   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ACICLOVIR; ALPHA INTERFERON; AMANTADINE; CIDOFOVIR; FOSCARNET; GANCICLOVIR; HYDROCORTISONE; LACTATE DEHYDROGENASE; LOPINAVIR; METHYLPREDNISOLONE; NEVIRAPINE; RIBAVIRIN; RITONAVIR; STAVUDINE; ZIDOVUDINE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGE; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG POTENTIATION; FEMALE; GASTROINTESTINAL DISEASE; HEADACHE; HEPATITIS B; HOSPITAL INFECTION; HUMAN; IN VITRO STUDY; LIVER DYSFUNCTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NONHUMAN; PATIENT MONITORING; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; REDUCTION; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; SIDE EFFECT; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VIRUS CARRIER; VIRUS LOAD; VISUAL IMPAIRMENT;

ADULT; AGED; CROSS INFECTION; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; FEMALE; HIV PROTEASE INHIBITORS; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PYRIMIDINONES; RITONAVIR; SEVERE ACUTE RESPIRATORY SYNDROME; STEROIDS; TREATMENT OUTCOME; VIRAL LOAD;

EID: 12144290587     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.2003.012658     Document Type: Article

References (20)

1. Peiris JS, Lai ST, Poon LL, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003;361:1319-25.
2. Ksiazek TG, Erdman D, Goldsmith CS, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003;348:1953-66.
3. Drosten C, Gunther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003;348:1967-76.
4. Fouchier RA, Kuiken T, Schutten M, et al. Aetiology: Koch's postulates fulfilled for SARS virus. Nature 2003;423:240.
5. Peiris JS, Chu CM, Cheng VC, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 2003;361:1767-72.
6. Falsey AR, Walsh EE. Novel coronavirus and severe acute respiratory syndrome. Lancet 2003;361:1312-3.
7. So LK, Lau AC, Yam LY, et al. Development of a standard treatment protocol for severe acute respiratory syndrome. Lancet 2003;361:1615-7.
8. Bernard GR, Artigas A, Brigham KL, et al. The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149:818-24.
9. Nicholls JM, Poon LL, Lee KC, et al. Lung pathology of fatal severe acute respiratory syndrome. Lancet 2003;361:1773-8.
10. Hurst M, Faulds D. Lopinavir. Drugs 2000;60:1371-9.
11. Cvetkovic RS, Goa KL. Lopinavir/ritonavir: a review of its use in the management of HIV infection. Drugs 2003;63:769-802.
12. Booth CM, Matukas LM, Tomlinson GA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the Greater Toronto area. JAMA 2003;289:2801-9.
13. Lee N, Hui D, Wu A, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003;348:1986-94.
14. Wong RS, Wu A, To KF, et al. Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. BMJ 2003;326:1358-62.
15. Chan JW, Ng CK, Chan YH, et al. Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS). Thorax 2003;58:686-9.
16. Donnelly CA, Ghani AC, Leung GM, et al. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet 2003;361:1761-6.
17. World Health Organization. Summary table of SARS cases by country, 1 November 2002-7 August 2003 (available at www.who.int/csr/sars/ country/en/country2003_08_15.pdf, accessed 8 September 2003).
18. Anon. Update: severe acute respiratory syndrome - United States, 2003. MMWR Morb Mortal Wkly Rep 2003;52:616.
19. Tsang KW, Lam WK. Management of severe acute respiratory syndrome. The Hong Kong University experience. Am J Respir Crit Care Med 2003;168:417-24.
20. Ho JC, Ooi GC, Mok TY, et al. High dose pulse versus non-pulse corticosteroid regimens in severe acute respiratory syndrome. Am J Respir Crit Care Med 2003;168:1449-56.